Evidence map›Paper›PMID 42353077›Full record

ArticleInternational journal of molecular sciences2026

CD44-Hyaluronan-Dependent Monocyte Rolling.

Marcus Hubbe, Robert H Eibl

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Marcus HubbeLaboratory of Immunology and Vascular Biology, Department of Pathology, Stanford University, Stanford, CA 94305, USA.ORCID 0009-0004-2251-0391
Robert H EiblLaboratory of Immunology and Vascular Biology, Department of Pathology, Stanford University, Stanford, CA 94305, USA.ORCID 0000-0002-6687-5286

Funding

National Institute of Allergy and Infectious Diseases 1R01-AI-130471National Institute of Allergy and Infectious Diseases R01 AI-047822
6 · The paper itself

Abstract

Leukocyte recruitment from blood into tissues involves sequential adhesive steps, including rolling and integrin-dependent arrest. VLA-4 can support firm adhesion and, in some settings, rolling interactions, whereas CD44-hyaluronan interactions have also been implicated in leukocyte rolling. Here, we used adhesion assays and parallel-plate flow chamber experiments to analyze CD44-hyaluronan-dependent monocyte interactions on ECV304 monolayers and to compare them with α4-integrin-sensitive adhesion on endothelial monolayers. WEHI 78/24 monocytoid cells interacted with ECV304 monolayers in a CD44- and hyaluronan-dependent manner, whereas adhesion to HMEC-1 and bEnd.3 monolayers was sensitive to α4-integrin blockade. Blocking CD44, adding soluble hyaluronan, or treating ECV304 monolayers with hyaluronidase reduced adhesion and rolling. Mixed primary human monocyte preparations also showed CD44-dependent adhesion and rolling on ECV304 monolayers. ECV304 cells are interpreted here not as endothelial cells, but as T24-derived, hyaluronidase-sensitive cellular monolayers useful for functional analysis of CD44-hyaluronan-dependent interactions. These findings support a substrate-dependent functional hierarchy in which CD44-hyaluronan-dependent monocyte rolling becomes detectable when α4-integrin-dependent adhesion is not dominant, while emphasizing the cell-model-based nature of the assay.

Indexed as

Hyaluronan ReceptorsHyaluronic AcidLeukocyte RollingMonocytesCell AdhesionCell LineEndothelial CellsHumansCD44 protein, humanHyaluronan ReceptorsHyaluronic AcidCD44cell adhesionHA)hyaluronan (hyaluronateleukocyte traffickingmonocyteparallel-plate flow chamberrollingVCAM-1VLA-4

Identifiers

PMID42353077
PMCPMC13299323

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.